EC Number |
Recommended Name |
Source Tissue |
Reference |
---|
2.3.1.67 | 1-alkylglycerophosphocholine O-acetyltransferase |
central nervous system |
primary cultured cells of |
688161 |
2.7.1.149 | 1-phosphatidylinositol-5-phosphate 4-kinase |
central nervous system |
- |
738389 |
3.1.4.37 | 2',3'-cyclic-nucleotide 3'-phosphodiesterase |
central nervous system |
- |
135380, 135384, 135385, 135393, 135397, 135400, 135422, 670668, 750212, 752180 |
1.3.1.22 | 3-oxo-5alpha-steroid 4-dehydrogenase (NADP+) |
central nervous system |
- |
676162 |
3.1.1.7 | acetylcholinesterase |
central nervous system |
- |
749734 |
3.1.1.7 | acetylcholinesterase |
central nervous system |
and organs controlled by |
114160 |
3.1.1.7 | acetylcholinesterase |
central nervous system |
expression analysis |
682914 |
3.1.1.7 | acetylcholinesterase |
central nervous system |
isoform AChE2 is predominately expressed in the central nervous system (CNS) while isoform AChE1 is abundantly observed not only in the CNS but also in the peripheral nervous system/non-neuronal tissues |
730711 |
3.4.24.B11 | ADAMTS1 endopeptidase |
central nervous system |
- |
668117 |
2.7.1.20 | adenosine kinase |
central nervous system |
- |
661642 |
1.2.3.1 | aldehyde oxidase |
central nervous system |
- |
691701 |
1.2.3.1 | aldehyde oxidase |
central nervous system |
presence of the AOX1 transcript in the glial cell population of the spinal cord |
691701 |
3.1.4.39 | alkylglycerophosphoethanolamine phosphodiesterase |
central nervous system |
cancer cell line |
6, 663457 |
3.1.4.39 | alkylglycerophosphoethanolamine phosphodiesterase |
central nervous system |
high levels of expression are detected in peripheral tissues, lower expression levels are observed in the central nervous system. Autotaxin isoform alpha exhibits the lowest expression levels both in the central nervous system and peripheral tissues among the three isoforms. Tissue distribution of the three isoforms alpha, beta, and gamma |
680925 |
2.4.1.155 | alpha-1,6-mannosyl-glycoprotein 6-beta-N-acetylglucosaminyltransferase |
central nervous system |
of the embryo |
638552 |
3.2.1.1 | alpha-amylase |
central nervous system |
ventral nerve cord |
664762 |
5.1.1.10 | amino-acid racemase |
central nervous system |
DAR1 is localized to the medial region of the cerebral ganglion where the F- and C-clusters are situated |
715591 |
4.1.1.19 | arginine decarboxylase |
central nervous system |
- |
747422 |
2.7.3.3 | arginine kinase |
central nervous system |
- |
642475 |
2.3.2.8 | arginyltransferase |
central nervous system |
- |
758964 |
3.5.1.15 | aspartoacylase |
central nervous system |
immunohistochemical localization analysis, high enzyme content in oligodendrocytes along with CC1, and in white matter, including the corpus callosum and the cerebellar white matter, less abundant enzyme content in grey matter, including cerebral cortex, descending neuronal fibers, and microglial cells, no enzyme in astroyctes and forebrain, overview |
669635 |
2.7.11.15 | beta-adrenergic-receptor kinase |
central nervous system |
- |
662332 |
3.4.13.20 | beta-Ala-His dipeptidase |
central nervous system |
- |
683621 |
3.4.13.20 | beta-Ala-His dipeptidase |
central nervous system |
the enzyme is enriched in several specific neuronal populations in the central nervous system |
669145 |
6.3.1.17 | beta-citrylglutamate synthase |
central nervous system |
- |
725404 |
6.3.2.B11 | beta-citrylglutamate synthase |
central nervous system |
- |
725404 |
2.4.3.1 | beta-galactoside alpha-(2,6)-sialyltransferase |
central nervous system |
expressed during embryonic development in a tissue- and stage-specific fashion, with elevated expression in a subset of cells within the central nervous system |
659397 |
3.4.22.40 | bleomycin hydrolase |
central nervous system |
histological examination, increase in GFAP-positively stained astroglia observed in the brains of aged null mice compared with wild-type controls |
683931 |
2.6.1.42 | branched-chain-amino-acid transaminase |
central nervous system |
- |
721137 |
2.7.11.17 | Ca2+/calmodulin-dependent protein kinase |
central nervous system |
- |
666114, 666122, 666127 |
2.7.11.17 | Ca2+/calmodulin-dependent protein kinase |
central nervous system |
during embryogenesis, larval and pupal life, transcription of caki is restricted almost exclusively to the central nervous system |
491292 |
2.7.11.17 | Ca2+/calmodulin-dependent protein kinase |
central nervous system |
expressed in great quantities in the central nervous system in the late embryonic stage of development |
491274 |
3.4.22.B25 | calpain 5 |
central nervous system |
- |
-, 732139 |
3.4.22.B25 | calpain 5 |
central nervous system |
CAPN5 signals are widely detected and are especially strong in the hippocampal formation and the piriform cortex |
754701 |
3.4.22.B25 | calpain 5 |
central nervous system |
high expression level |
-, 732139 |
4.2.1.1 | carbonic anhydrase |
central nervous system |
- |
666735, 748270 |
3.4.17.1 | carboxypeptidase A |
central nervous system |
- |
668122 |
3.4.17.12 | carboxypeptidase M |
central nervous system |
- |
697395 |
3.4.22.41 | cathepsin F |
central nervous system |
distribution, overview |
670246 |
3.4.22.27 | cathepsin S |
central nervous system |
- |
697041 |
3.4.18.1 | cathepsin X |
central nervous system |
healthy, aging, and pathological, expression patterns of cathepsin X, overview |
683448 |
2.7.11.12 | cGMP-dependent protein kinase |
central nervous system |
- |
662962 |
1.14.15.15 | cholestanetriol 26-monooxygenase |
central nervous system |
- |
713175 |
1.14.15.15 | cholestanetriol 26-monooxygenase |
central nervous system |
expression pattern of Cyp27a1 and other related genes in primary cultures of glia and neurons |
705935 |
1.14.14.25 | cholesterol 24-hydroxylase |
central nervous system |
- |
-, 735602 |
1.14.14.25 | cholesterol 24-hydroxylase |
central nervous system |
almost exclusive expression of gene CYP46A1 |
684856 |
3.1.1.8 | cholinesterase |
central nervous system |
- |
751209 |
2.7.11.22 | cyclin-dependent kinase |
central nervous system |
- |
662688, 760478 |
2.7.11.22 | cyclin-dependent kinase |
central nervous system |
primary localization of CDK5 |
662688 |
4.2.1.22 | cystathionine beta-synthase |
central nervous system |
cystathionine beta-synthase is associated with the generation and/or differentiation of the radial glia/astrocyte lineage cells in the developing central nervous system |
664879 |
3.4.11.3 | cystinyl aminopeptidase |
central nervous system |
- |
669637 |
1.4.3.3 | D-amino-acid oxidase |
central nervous system |
- |
700451, 742603 |
1.4.3.3 | D-amino-acid oxidase |
central nervous system |
DAO is restricted to the lower brainstem, cerebellum and spinal cord, decreasing levels in the midbrain, the cortex and hippocampus |
699761 |
3.1.1.96 | D-aminoacyl-tRNA deacylase |
central nervous system |
most intense expression is observed in hippocampal pyramidal cells, cerebellar Purkinje cells and most layers of the cerebral cortex |
724218 |
2.7.1.107 | diacylglycerol kinase (ATP) |
central nervous system |
DGKbeta |
640382 |
2.7.1.107 | diacylglycerol kinase (ATP) |
central nervous system |
isozyme DGK-theta shows a striking predominate localization in the nervous system |
737399 |
1.3.5.2 | dihydroorotate dehydrogenase (quinone) |
central nervous system |
regiospecific distribution of DHODH, immunohistochemic analysis, overview |
713150 |
3.1.8.2 | diisopropyl-fluorophosphatase |
central nervous system |
- |
751626 |
3.4.14.4 | dipeptidyl-peptidase III |
central nervous system |
in larva |
668562 |
2.1.1.37 | DNA (cytosine-5-)-methyltransferase |
central nervous system |
- |
700956 |
5.6.2.1 | DNA topoisomerase |
central nervous system |
level of topo I increases from birth to maturity and decreases, more significantly in males, with senescence |
662523 |
5.6.2.2 | DNA topoisomerase (ATP-hydrolysing) |
central nervous system |
- |
-, 714804 |
4.2.99.18 | DNA-(apurinic or apyrimidinic site) lyase |
central nervous system |
APE1 is highly expressed in selected regions of the central nervous system |
690474 |
3.4.24.35 | gelatinase B |
central nervous system |
localized mainly in the cytoplasm of neoplastic astrocytes |
734590 |
3.1.3.9 | glucose-6-phosphatase |
central nervous system |
- |
134923 |
2.4.1.174 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase |
central nervous system |
- |
759849 |
3.4.17.21 | Glutamate carboxypeptidase II |
central nervous system |
- |
668106, 670363, 670817 |
3.5.1.2 | glutaminase |
central nervous system |
GLS1 |
669950 |
2.3.2.5 | glutaminyl-peptide cyclotransferase |
central nervous system |
- |
759702 |
1.3.8.6 | glutaryl-CoA dehydrogenase (ETF) |
central nervous system |
- |
391407 |
1.8.5.1 | glutathione dehydrogenase (ascorbate) |
central nervous system |
- |
394027 |
2.1.4.1 | glycine amidinotransferase |
central nervous system |
- |
688183, 690097 |
1.4.1.27 | glycine cleavage system |
central nervous system |
- |
758983 |
2.4.2.38 | glycoprotein 2-beta-D-xylosyltransferase |
central nervous system |
- |
394590 |
2.7.1.183 | glycoprotein-mannosyl O6-kinase |
central nervous system |
- |
762091 |
2.1.1.2 | guanidinoacetate N-methyltransferase |
central nervous system |
- |
688183 |
4.6.1.2 | guanylate cyclase |
central nervous system |
atypical sGC primarily expressed |
681233 |
1.13.11.52 | indoleamine 2,3-dioxygenase |
central nervous system |
- |
657493 |
2.7.1.127 | inositol-trisphosphate 3-kinase |
central nervous system |
- |
700975, 762015 |
3.4.24.56 | insulysin |
central nervous system |
- |
696530 |
3.4.24.7 | interstitial collagenase |
central nervous system |
- |
709370 |
2.1.1.325 | juvenile hormone-III synthase |
central nervous system |
highest expression |
738375 |
3.4.21.118 | kallikrein 8 |
central nervous system |
- |
680086 |
3.4.21.118 | kallikrein 8 |
central nervous system |
high expression level |
647332 |
3.4.21.61 | Kexin |
central nervous system |
- |
731241 |
1.14.13.9 | kynurenine 3-monooxygenase |
central nervous system |
- |
689224, 763915, 765242 |
1.1.3.8 | L-gulonolactone oxidase |
central nervous system |
- |
636311 |
3.1.1.34 | lipoprotein lipase |
central nervous system |
- |
-, 750657 |
1.3.8.8 | long-chain acyl-CoA dehydrogenase |
central nervous system |
- |
671275, 671771 |
3.2.1.113 | mannosyl-oligosaccharide 1,2-alpha-mannosidase |
central nervous system |
In situ hybridization shows high levels of alpha1,2-mannosidase IB |
680806 |
3.4.11.2 | membrane alanyl aminopeptidase |
central nervous system |
- |
665113 |
1.5.1.20 | methylenetetrahydrofolate reductase [NAD(P)H] |
central nervous system |
all regions |
392161 |
2.7.12.2 | mitogen-activated protein kinase kinase |
central nervous system |
Mkk4 transcripts confined to the central nervous system in early embryogenesis, up to embryonic day 10 |
682214 |
2.7.11.18 | myosin-light-chain kinase |
central nervous system |
- |
673994 |
6.3.2.41 | N-acetylaspartylglutamate synthase |
central nervous system |
- |
725404 |
6.3.2.42 | N-acetylaspartylglutamylglutamate synthase |
central nervous system |
highest expression levels in the brain stem and spinal cord, almost undetectable in the neocortex |
725423 |
2.4.1.122 | N-acetylgalactosaminide beta-1,3-galactosyltransferase |
central nervous system |
- |
759109 |
2.4.1.122 | N-acetylgalactosaminide beta-1,3-galactosyltransferase |
central nervous system |
during embryogenesis, in late embryos at stage 16 |
703884 |
2.4.1.122 | N-acetylgalactosaminide beta-1,3-galactosyltransferase |
central nervous system |
in embryo |
703369 |
2.7.7.43 | N-acylneuraminate cytidylyltransferase |
central nervous system |
robust expression in the entire central nervous system, the somites, the notochord, and the developing pronephric duct |
722748 |